Although genetic and epigenetic changes activate Wnt/β-catenin signaling to drive the progression of prostate cancer [235], it is not commonly observed for CTNNB1, APC, and AXIN1 genes to undergo mutations in prostate cancer [236]. This evidence concerns the gene CTNNB1 and prostate carcinoma.